Jump to content
RemedySpot.com

Risk of authoritarianism: fibrinogen-transmitted hepatitis C in Japan

Rate this topic


Guest guest

Recommended Posts

http://www.thelancet.com/journals/lancet/article/PIIS0140673607618674/abstract

The Lancet 2007; 370:2063-2067

DOI:10.1016/S0140-6736(07)61867-4

Public Health

Risk of authoritarianism: fibrinogen-transmitted hepatitis C in Japan

Hideo Yasunaga MD a

Summary

In 1977, the US Food and Drug Administration revoked all licences for fibrinogen

concentrate because of the risk for hepatitis infection and suspected lack of

effectiveness. However, in Japan, fibrinogen concentrate was used routinely for

treatment of obstetric bleeding until 1988. Even in 1997, academic texts by

Japanese authorities in obstetrics still recommended that obstetricians use the

product. An estimated 10 000 cases of hepatitis C infection are attributable

to use of fibrinogen in Japan and are a result of authoritarianism that hindered

effective policy changes. Scientists have a duty to refine repeatedly the

quality of their evidence, and policymakers need to adjust existing policies

continually to accord with the latest scientific evidence.

Affiliations

a. Department of Planning, Information and Management, University of Tokyo

Hospital, Tokyo, Japan

Correspondence to: Hideo Yasunaga, Department of Planning, Information and

Management, University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan

_________________________________________________________________

Get the power of Windows + Web with the new Windows Live.

http://www.windowslive.com?ocid=TXT_TAGHM_Wave2_powerofwindows_122007

Link to comment
Share on other sites

http://www.thelancet.com/journals/lancet/article/PIIS0140673607618674/abstract

The Lancet 2007; 370:2063-2067

DOI:10.1016/S0140-6736(07)61867-4

Public Health

Risk of authoritarianism: fibrinogen-transmitted hepatitis C in Japan

Hideo Yasunaga MD a

Summary

In 1977, the US Food and Drug Administration revoked all licences for fibrinogen

concentrate because of the risk for hepatitis infection and suspected lack of

effectiveness. However, in Japan, fibrinogen concentrate was used routinely for

treatment of obstetric bleeding until 1988. Even in 1997, academic texts by

Japanese authorities in obstetrics still recommended that obstetricians use the

product. An estimated 10 000 cases of hepatitis C infection are attributable

to use of fibrinogen in Japan and are a result of authoritarianism that hindered

effective policy changes. Scientists have a duty to refine repeatedly the

quality of their evidence, and policymakers need to adjust existing policies

continually to accord with the latest scientific evidence.

Affiliations

a. Department of Planning, Information and Management, University of Tokyo

Hospital, Tokyo, Japan

Correspondence to: Hideo Yasunaga, Department of Planning, Information and

Management, University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan

_________________________________________________________________

Get the power of Windows + Web with the new Windows Live.

http://www.windowslive.com?ocid=TXT_TAGHM_Wave2_powerofwindows_122007

Link to comment
Share on other sites

http://www.thelancet.com/journals/lancet/article/PIIS0140673607618674/abstract

The Lancet 2007; 370:2063-2067

DOI:10.1016/S0140-6736(07)61867-4

Public Health

Risk of authoritarianism: fibrinogen-transmitted hepatitis C in Japan

Hideo Yasunaga MD a

Summary

In 1977, the US Food and Drug Administration revoked all licences for fibrinogen

concentrate because of the risk for hepatitis infection and suspected lack of

effectiveness. However, in Japan, fibrinogen concentrate was used routinely for

treatment of obstetric bleeding until 1988. Even in 1997, academic texts by

Japanese authorities in obstetrics still recommended that obstetricians use the

product. An estimated 10 000 cases of hepatitis C infection are attributable

to use of fibrinogen in Japan and are a result of authoritarianism that hindered

effective policy changes. Scientists have a duty to refine repeatedly the

quality of their evidence, and policymakers need to adjust existing policies

continually to accord with the latest scientific evidence.

Affiliations

a. Department of Planning, Information and Management, University of Tokyo

Hospital, Tokyo, Japan

Correspondence to: Hideo Yasunaga, Department of Planning, Information and

Management, University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan

_________________________________________________________________

Get the power of Windows + Web with the new Windows Live.

http://www.windowslive.com?ocid=TXT_TAGHM_Wave2_powerofwindows_122007

Link to comment
Share on other sites

http://www.thelancet.com/journals/lancet/article/PIIS0140673607618674/abstract

The Lancet 2007; 370:2063-2067

DOI:10.1016/S0140-6736(07)61867-4

Public Health

Risk of authoritarianism: fibrinogen-transmitted hepatitis C in Japan

Hideo Yasunaga MD a

Summary

In 1977, the US Food and Drug Administration revoked all licences for fibrinogen

concentrate because of the risk for hepatitis infection and suspected lack of

effectiveness. However, in Japan, fibrinogen concentrate was used routinely for

treatment of obstetric bleeding until 1988. Even in 1997, academic texts by

Japanese authorities in obstetrics still recommended that obstetricians use the

product. An estimated 10 000 cases of hepatitis C infection are attributable

to use of fibrinogen in Japan and are a result of authoritarianism that hindered

effective policy changes. Scientists have a duty to refine repeatedly the

quality of their evidence, and policymakers need to adjust existing policies

continually to accord with the latest scientific evidence.

Affiliations

a. Department of Planning, Information and Management, University of Tokyo

Hospital, Tokyo, Japan

Correspondence to: Hideo Yasunaga, Department of Planning, Information and

Management, University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan

_________________________________________________________________

Get the power of Windows + Web with the new Windows Live.

http://www.windowslive.com?ocid=TXT_TAGHM_Wave2_powerofwindows_122007

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...